The conclusion of a University of New South Wales study coincides with the addition of a powerful new anti-viral treatment to the Pharmaceutical Benefits Scheme. (PBS)
The conclusion of a University of New South Wales study coincides with the addition of a powerful new anti-viral treatment to the Pharmaceutical Benefits Scheme. (PBS)